The KRAS gene mutation, responsible for a quarter of all cancerous tumors, has met its match. Thanks to UCSF research, a tiny ...

A new study, with help from artificial intelligence, focuses on reprogramming cancer stem cells and triggering some to ‘self-destruct’ ...

What is it like to be diagnosed with colon cancer in your 20s, 30s, or 40s? In this episode of Life Lessons, five young ...

Today, the Colorectal Cancer Alliance’s Project Cure CRC announced new grants supporting 3 research projects at La Jolla Institute for Immunology, Virginia Tech, and the University of Arizona. 1 These ...

Dr. Joshua Sabari sat down with Dr. Michael Cecchini to discuss advances in colorectal cancer management and key data ...

For years, a diagnosis of colon cancer meant potential surgery followed by a painful round of chemotherapy to kill the remaining cancer cells. One-size-fits-all treatment was normal. A new blood test ...

ABT-301, an HDAC1/2/3 inhibitor, enhances immune response and tumor microenvironment, potentially improving immune checkpoint inhibitor efficacy in metastatic colorectal cancer. The phase 1/2 trial ...

Defining cure in stage II and III colon cancer has been challenging, and has never been systematically studied. In an analysis of 15 randomized trials, colon cancer relapse risk fell to 0.5% by year 6 ...

GLP-1 medications may help colon cancer patients live longer by reducing inflammation and improving metabolic health, UC San ...

Ozempic and Wegovy may be doing more than helping users drop pounds. A new study from the University of California, San Diego, has found a strong link between GLP-1 medications […] The post Ozempic ...

There is a taboo about colon cancer,” the Overland Park native said. “People don’t want to be informed. People want to ignore.” ...

Researchers at Baylor Scott & White Research Institute identified a new genetic biomarker for colon cancer that may lead to development of more targeted treatment of the disease. The study, which ...